Candriam SCA’s Organon & Co OGN Stock Holding History

Candriam SCA’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,486	Closed	-$443K	–	826
2023 Q1	$443K	Buy	+20,486	New	+$550K	﹤0.01%	793
2021 Q3	–	Sell	-51,274	Closed	-$1.55M	–	898
2021 Q2	$1.55M	Buy	+51,274	New	+$1.69M	0.01%	634

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Candriam SCA's OGN Position: Q2 2023 in Review

Candriam SCA sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 20,486 shares — an estimated $443K sold.

Candriam SCA first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $1.55M in Q2 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Candriam SCA reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 20,486 Organon & Co shares in Q2 2023, an estimated $443K.
Candriam SCA first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
Candriam SCA's Organon & Co position peaked at $1.55M in Q2 2021.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.